Gastritis, Atrophic
Welcome,         Profile    Billing    Logout  
 5 Companies   2 Products   2 Products   1 Mechanism of Action   1 Trial   31 News 
  • ||||||||||  Trial completion, Trial completion date:  VOLGACORE: Volatile Markers in Digestive Cancer (clinicaltrials.gov) -  Aug 21, 2018   
    P=N/A,  N=2022, Completed, 
    Trial completion date: Nov 2018 --> Dec 2023 | Trial primary completion date: Oct 2018 --> Dec 2023 Recruiting --> Completed | Trial completion date: Dec 2017 --> Jun 2017
  • ||||||||||  Trial completion, Enrollment change, Trial initiation date:  Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy (clinicaltrials.gov) -  Mar 16, 2017   
    P=N/A,  N=253, Completed, 
    Recruiting --> Completed | Trial completion date: Dec 2017 --> Jun 2017 Active, not recruiting --> Completed | N=100 --> 253 | Initiation date: Apr 2016 --> Sep 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Helicobacter Pylori and Proton Pump Inhibitor (clinicaltrials.gov) -  Dec 6, 2016   
    P=N/A,  N=30, Completed, 
    Not yet recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Feb 2016 --> Dec 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis (clinicaltrials.gov) -  Apr 20, 2016   
    P=N/A,  N=200, Completed, 
    Recruiting --> Completed | N=100 --> 72 | Trial primary completion date: Jan 2016 --> Apr 2016 Recruiting --> Completed | Trial primary completion date: Jun 2011 --> Jun 2012
  • ||||||||||  Trial completion, Enrollment change:  L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde (clinicaltrials.gov) -  Jan 25, 2016   
    P2,  N=8, Completed, 
    Recruiting --> Completed | Trial primary completion date: Jun 2011 --> Jun 2012 Enrolling by invitation --> Completed | N=12 --> 8
  • ||||||||||  netazepide (YF476) / Trio Medicines
    Enrollment change, Trial termination, Trial primary completion date:  YF476 and Type I Gastric Carcinoids (Norway) (clinicaltrials.gov) -  May 16, 2015   
    P2,  N=8, Terminated, 
    Enrolling by invitation --> Completed | N=12 --> 8 N=10 --> 8 | Enrolling by invitation --> Terminated | Trial primary completion date: Nov 2012 --> May 2012; Difficulties with recruitment
  • ||||||||||  Trial primary completion date:  New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy (clinicaltrials.gov) -  May 8, 2014   
    P=N/A,  N=272, Completed, 
    N=10 --> 8 | Enrolling by invitation --> Terminated | Trial primary completion date: Nov 2012 --> May 2012; Difficulties with recruitment Trial primary completion date: Aug 2013 --> Sep 2013
  • ||||||||||  netazepide (YF476) / Trio Medicines
    New P2 trial:  YF476 and Type I Gastric Carcinoids (Norway) (clinicaltrials.gov) -  Sep 27, 2011   
    P2,  N=10, Enrolling by invitation,